Not all patients with deterioration in pulmonary function tests have a progressive disease: 30% of patients develop progressive lung disease and only 16% will develop severe lung fibrosis (defined ...

The FDA granted elraglusib a rare pediatric disease designation for Ewing sarcoma based on findings from the 1/2 Actuate-1902 ...

Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease-free survival (DFS) but not overall survival (OS) at 10 years, and doubled the risk ...

Cyclophosphamide 500mg, 1g, 2g; per vial; pwd for inj after reconstitution; preservative-free. Cyclophosphamide is biotransformed principally in the liver to active alkylating metabolites by a ...

Get detailed information on Cyclophosphamide, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

1 The purpose of ALMS was to demonstrate the superiority of mycophenolate mofetil (MMF) over intravenous cyclophosphamide for the induction of remission in patients with lupus nephritis.

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP) ...

A study by Mellqvist et al. has assessed the efficacy and safety of combined bolus-dose cyclophosphamide and pulse-dose dexamethasone (Cy-Dex) as initial treatment for patients with myeloma.

Medindia neither buys nor sells drugs. Cyclophosphamide (Cyclomet) is an antineoplastic agent, prescribed for many types of cancers like lymphatic cancer, cancer of white blood cells and plasma ...